The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 06, 2024

Filed:

Dec. 17, 2021
Applicant:

Sami-sabinsa Group Limited, Bangalore, IN;

Inventors:

Muhammed Majeed, Bangalore, IN;

Kalyanam Nagabhushanam, East Windsor, NJ (US);

Lakshmi Mundkur, Bangalore, IN;

A. Muhamad Ibrahim, Bangalore, IN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 36/9066 (2006.01); A23L 33/105 (2016.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 31/12 (2006.01); A61K 31/19 (2006.01); A61K 31/23 (2006.01); A61K 36/324 (2006.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01); A61K 47/42 (2017.01); A61P 3/06 (2006.01); A61P 19/02 (2006.01); A61P 39/06 (2006.01);
U.S. Cl.
CPC ...
A61K 36/9066 (2013.01); A23L 33/105 (2016.08); A61K 9/0053 (2013.01); A61K 9/0056 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/4866 (2013.01); A61K 31/12 (2013.01); A61K 31/19 (2013.01); A61K 31/23 (2013.01); A61K 36/324 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61K 47/42 (2013.01); A61P 3/06 (2018.01); A61P 19/02 (2018.01); A61P 39/06 (2018.01);
Abstract

A composition enriched with bisdemethoxycurcumin standardized to contain 20-80% w/w bisdemethoxycurcumin, 10-35% w/w demethoxycurcumin and 10-50% w/w curcumin. More specifically the invention discloses the potential of a composition comprising 20-80% w/w bisdemethoxycurcumin, 10-35% w/w demethoxycurcumin and 10-50% w/w curcumin in the management of nephrotoxicity in mammals. The composition further comprises aextract standardised to contain not less than 2% w/w thymoquinone and about 0.01%-10% w/w thymohydroquinone.


Find Patent Forward Citations

Loading…